Research and Markets: Molecular Biomarkers for Clinical Diagnostics and Drug Discovery and Development
Research and Markets (http://www.researchandmarkets.com ) has announced the addition of Molecular Biomarkers for Clinical Diagnostics and Drug Discovery and Development to their offering.
This report is about the market for molecular biomarkers for clinical diagnostics and for drug discovery and development. The research reviews the market segments by major diseases, by application areas, and by technologies.
This study surveyed the activities of more than 60 companies that are participating in this industry. The report analyzed the future direction of biomarkers, molecular diagnostics and pharmaco-genomic tests used in drug discovery and development.
This new report has found that the worldwide market size for molecular biomarkers, diagnostics and related molecular clinical lab services in 2003 was about $6.1 billion. The diagnostics and pharmaceutical industries each face numerous challenges that could be helped with newer business approaches that are discussed in this report. The molecular diagnostics companies are set for strong growth.
The report discusses new FDA initiatives to accelerate the approvals of diagnostics and new drugs by integrating biomarkers and pharmacogenomic tests into the drug discovery and development steps including clinical trials. The report discusses these important items with interesting and useful findings.
This study uses more than 23 figures and 47 tables to illustrate the findings. Detailed information includes several large tables about company activities, strategic alliances, technologies and so on. Twenty-three companies are profiled including details about contact information, business overview, financial details and product pipelines.
This report is available in either English or Japanese
Report Contents:
1. Major Diseases, Biomarkers and Diagnostics
— 1.1 The Size of Major Disease Populations
2. What Biomarkers and Tests Are
— 2.1 Biomarker Definitions
— 2.2 The In-Vitro Diagnostics (IVD) Industry
— 2.3 Biomarkers and Genetic Diagnostic Tests
— 2.4 Biomarker Advances
— 2.5 Developing Molecular Biomarker Tests
3. Company Activities: Molecular Biomarker Tests in Clinical Diagnostics
— 3.1 Major Participants by Disease Segment
— 3.2 Important Findings or Special Notes
4. Technology: Developing Molecular Biomarker Tests for Clinical Diagnostics & Commercial Implication
— 4.1 Recent Important Molecular Biomarker Test Discoveries
— 4.2 Drug Discovery Research & Development
— 4.3 Commercial Implications of Biomarker based Assays or Diagnostics
5. Company Activities: Biomarkers and Tests in Drug Discovery and Development
— 5.1 Major Participants by Disease Segment
— 5.2 Important Findings or Special Notes
6. R&D Activity and Alliances for Biomarkers/ Molecular Diagnostics
— 6.1 Overview of R&D & Alliances in Biomarker/ Molecular Diagnostics and in Drug Discovery R&D
— 6.2 R&D Activity and Strategic Alliances
7. The Market Size and Forecast for Biomarker Clinical Diagnostics
— 7.1 Market Overview: Biomarker Clinical Diagnostics & Lab Services
— 7.2 WW Biomarker Clinical Diagnostic Product Market Trends
— 7.3 Molecular Biomarker Clinical Diagnostic Product Market Share
— 7.4 WW Biomarker Clinical Diagnostic Market Size by Application Segment
— 7.5 WW Biomarker Diagnostic Market Size by Region
— 7.6 WW Biomarker Diagnostic Lab Services Market Size by Applications and Regions
8. Future Directions
— 8.1 Major Trends for Molecular Biomarkers and Diagnostics
— 8.2 Best Opportunities for the Future
— 8.3 Main Challenges
9. The Market Size and Forecast for Biomarkers in Drug Discovery and Development
— 9.1 WW Biomarkers in Drug Discovery and Development Market Trends
— 9.2 WW Biomarkers in Drug Discovery and Development, Disease Market Shares
— 9.3 WW Biomarker in Drug Discovery and Development Market Size by Application Segments
— 9.4 WW Biomarker in Drug Discovery and Development Market Size by Region
10. Company Activities and Profiles In Biomarker Test R&D
— 10.1 Company Activities at a Glance
— 10.2 BioContent
— 10.3 Chemistry
— 10.4 IVD Manufacturer
— 10.5 R&D Service Provider
— 10.6 Software
— 10.7 Tech Platform
Table of Tables
List of Illustrations
For more information visit http://www.researchandmarkets.com/reports/c5044
